Itau Unibanco Holding S.A.’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-481
Closed -$65K 863
2019
Q1
$65K Hold
481
﹤0.01% 490
2018
Q4
$65K Sell
481
-7
-1% -$1.06K ﹤0.01% 490
2018
Q3
$83K Sell
488
-37
-7% -$6.22K ﹤0.01% 512
2018
Q2
$91K Sell
525
-104
-17% -$15.6K 0.01% 555
2018
Q1
$73K Buy
629
+411
+189% +$43.7K ﹤0.01% 455
2017
Q4
$18K Sell
218
-62
-22% -$5.17K ﹤0.01% 510
2017
Q3
$82K Sell
280
-720
-72% -$55.9K 0.01% 537
2017
Q2
$80K Buy
1,000
+904
+942% +$50.1K 0.01% 253
2017
Q1
$4K Buy
+96
New +$3.95K ﹤0.01% 667

Itau Unibanco Holding S.A.'s LOXO Position: Q2 2019 in Review

Itau Unibanco Holding S.A. sold out of Loxo Oncology, Inc (LOXO) in Q2 2019, closing a stake of 481 shares — an estimated $65K sold.

Itau Unibanco Holding S.A. first reported a position in LOXO in Q1 2017 and held it in 9 quarters. The position peaked at $91K in Q2 2018. 0 funds tracked by Wall St. Rank hold LOXO as of Q2 2019.

  • Itau Unibanco Holding S.A. reported no remaining Loxo Oncology, Inc position as of Q2 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 481 Loxo Oncology, Inc shares in Q2 2019, an estimated $65K.
  • Itau Unibanco Holding S.A. first reported a position in Loxo Oncology, Inc in Q1 2017 and held it in 9 quarters.
  • Itau Unibanco Holding S.A.'s Loxo Oncology, Inc position peaked at $91K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2019, filed 14 Aug 2019.